Castle Biosciences (CSTL) Return on Sales (2018 - 2026)

Castle Biosciences has reported Return on Sales for 9 years, with the latest figure at 0.0% in Q2 2026.

• Quarterly Return on Sales changed 0.0% year-over-year to 0.0% in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 0.0% (changed 0.0% YoY) and the FY2025 annual result came in at 0.0%, changed 0.0% from the prior year.
• Return on Sales climbed to 0.0% in Q2 2026 per CSTL's latest filing, from 0.0% in the prior quarter.
• Over five years, Return on Sales peaked at 0.0% in Q4 2024 and troughed at 0.01% in Q1 2022.
• A 5-year average of 0.0% and a median of 0.0% in 2022 frame the typical range for Return on Sales.
• The sharpest annual moves came in 2022 and 2024: Return on Sales decreased 1 bps in 2022, then rose 1 bps in 2024.
• Over 5 years, Return on Sales stood at 0.01% in 2022, then jumped by 93 bps to 0.0% in 2023, then soared by 385 bps to 0.0% in 2024, then slumped by 124 bps to 0.0% in 2025, then advanced by 26 bps to 0.0% in 2026.
• According to Business Quant data, Return on Sales over the past three periods registered 0.0%, 0.0%, and 0.0% for Q2 2026, Q1 2026, and Q4 2025 respectively.